|
(1) A very unique cancer(tumor) vaccine
It is a new and innovative cancer vaccine consisting
of formalin-fixed or paraffin-embedded tissue fragments
derived from patient's own cancer (tumor) and immunoadjuvants.
It is one of the self-vaccines
(auto-vaccines) without any
problematic adverse side effects.
The vaccine is promising to suppress the recurrence
of many types of human cancers after surgical resection.
(2) AFTVac is completely "personalized"
drug against cancer.
AFTVac is injected to the patient from whom the
cancerous tissue has been surgically resected.
AFTVac contains all the unknown cancer-associated
antigens restricted to that specific patient. The
immune cells in that patient will discriminate the
cancer cells from the normal cells after the AFTVac
injection (once every two weeks for a total of 3 injections
in an out-patient basis).
(3) Efficacy
AFTVac suppresses the recurrence
of hepatoma (liver cancer) after primary resection.
It markedly improves the patient's
overall survival rate . (We have published
these results in Clinical
Cancer Research, 10: 1574-1579, 2004.).
AFTVac have also been used in treating patients with
brain tumor (glioblastoma multiforme) who had developed
recurrence after prior primary resection. |
@
